Novo Nordisk A/S (NYSE:NVO)

Delayed Data
As of 4:00pm ET
 +1.06 / +0.67%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 23 analysts offering 12-month price forecasts for Novo Nordisk A/S have a median target of 156.00, with a high estimate of 179.08 and a low estimate of 97.56. The median estimate represents a -1.98% decrease from the last price of 159.15.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in Novo Nordisk A/S. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 27.55%
Growthannually 28.34%


Growthquarterly 1.66%
Growthannually 14.99%
Key to the earnings and sales forecast charts.